Lv41
610 积分 2023-12-06 加入
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
2小时前
待确认
C3-mediated extravascular hemolysis in PNH on eculizumab: Mechanism and clinical implications
4小时前
已完结
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
17天前
已完结
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
17天前
已完结
Type I interferon-stimulated genes predict clinical response to belimumab in systemic lupus erythematosus
17天前
已完结
Clinical outcomes of anifrolumab after belimumab failure in systemic lupus erythematosus: A single-center case series
17天前
已完结
IL-1 and IL-36 are the dominant cytokines in Palmar Plantar Pustulosis
18天前
已完结
Type I interferon-stimulated genes predict clinical response to belimumab in systemic lupus erythematosus
20天前
已完结
Reverse translation approach generates a signature of penetrating fibrosis in Crohn’s disease that is associated with anti-TNF response
24天前
已完结
Kinetic Characterization of Inhibition of Cathepsins L and S by Peptides With Anticancer Potential
2个月前
已完结
皖公网安备34019202002308
